Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "United States Nebulizer Market Report by Type, Modality, Applications, End Use, States and Company Analysis, 2025-2033" report has been added to ...

Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

The "Nebulizer Market Share Analysis and Size - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering. The Global Nebulizer Market is expected to reach US$ 2 ...

COPD emerged as an umbrella term for several respiratory diseases, including emphysema and chronic bronchitis, caused by lung damage. Because its effects are irreversible, early diagnosis and ...

Even after quitting, insurers continue to charge higher premiums, and former smokers or drinkers are still treated as ...

In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies working to turn scientific progress into lasting profits. Both companies, ...

Please provide your email address to receive an email when new articles are posted on . In those with and those without a history of CVD/metabolic disease, patients receiving dupilumab vs. placebo had ...

Both indoor and outdoor air quality impact chronic obstructive pulmonary disease (COPD), which opens up a large avenue to work with patients to improve their outcomes. For COPD patients, the adage ...

The Breathing Association, a Columbus-based nonprofit that helps 15,000 people with utility costs, faces closure due to the ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company’s ...

Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in ...